Anti-COLL2/ CLPSL2/ AAAL3045 functional antibody

Anti-COLL2/ CLPSL2/ AAAL3045 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CLPSL2/CLPSL2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0097-Ab-1/ GM-Tg-hg-SE0097-Ab-2Anti-Human CLPSL2 monoclonal antibodyHuman
GM-Tg-rg-SE0097-Ab-1/ GM-Tg-rg-SE0097-Ab-2Anti-Rat CLPSL2 monoclonal antibodyRat
GM-Tg-mg-SE0097-Ab-1/ GM-Tg-mg-SE0097-Ab-2Anti-Mouse CLPSL2 monoclonal antibodyMouse
GM-Tg-cynog-SE0097-Ab-1/ GM-Tg-cynog-SE0097-Ab-2Anti-Cynomolgus/ Rhesus macaque CLPSL2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0097-Ab-1/ GM-Tg-felg-SE0097-Ab-2Anti-Feline CLPSL2 monoclonal antibodyFeline
GM-Tg-cang-SE0097-Ab-1/ GM-Tg-cang-SE0097-Ab-2Anti-Canine CLPSL2 monoclonal antibodyCanine
GM-Tg-bovg-SE0097-Ab-1/ GM-Tg-bovg-SE0097-Ab-2Anti-Bovine CLPSL2 monoclonal antibodyBovine
GM-Tg-equg-SE0097-Ab-1/ GM-Tg-equg-SE0097-Ab-2Anti-Equine CLPSL2 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0097-Ab-1/ GM-Tg-hg-SE0097-Ab-2; GM-Tg-rg-SE0097-Ab-1/ GM-Tg-rg-SE0097-Ab-2;
GM-Tg-mg-SE0097-Ab-1/ GM-Tg-mg-SE0097-Ab-2; GM-Tg-cynog-SE0097-Ab-1/ GM-Tg-cynog-SE0097-Ab-2;
GM-Tg-felg-SE0097-Ab-1/ GM-Tg-felg-SE0097-Ab-2; GM-Tg-cang-SE0097-Ab-1/ GM-Tg-cang-SE0097-Ab-2;
GM-Tg-bovg-SE0097-Ab-1/ GM-Tg-bovg-SE0097-Ab-2; GM-Tg-equg-SE0097-Ab-1/ GM-Tg-equg-SE0097-Ab-2
Products NameAnti-CLPSL2 monoclonal antibody
Formatmab
Target NameCLPSL2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CLPSL2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0097-Ag-1Recombinant multi-species COLL2/ CLPSL2/ AAAL3045 protein


    Target information

    Target IDGM-SE0097
    Target NameCLPSL2
    Gene ID389383,328788,689425,100428674,100856297,101090519,100297290,100629442
    Gene Symbol and SynonymsAAAL3045,C23H6orf126,C6orf126,CLPSL2,dJ510O8.5,Gm749,UNQ3045
    Uniprot AccessionQ6UWE3,D3ZVN1
    Uniprot Entry NameCOLL2_HUMAN,COLL2_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000196748
    Target ClassificationN/A

    The target: CLPSL2, gene name: CLPSL2, also named as AAAL3045, C6orf126, UNQ3045, dJ510O8.5. Predicted to enable enzyme activator activity. Predicted to be involved in response to food. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.